Generic and biosimilar specialist Sandoz is strengthening its footprint in Slovenia, pledging $440 million to set up a new ...

A little over a year after Merck & Co. scored U.S. approval for its pulmonary arterial hypertension (PAH) newcomer Winrevair (sotatercept), the New Jersey drugmaker has locked in an expedited review ...

The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.

After taking aim at the United States’ vaccine safety reporting system earlier this year, Robert F. Kennedy Jr. | After ...

KKR sold off its 46.39% stake in J.B. Chemicals and Pharmaceuticals to Torrent Pharma after grooming the Indian drugmaker ...

As Dry Eye Awareness Month kicks off, Bausch + Lomb is rolling out a new campaign to improve education about the condition. | ...

Apellis and Sobi have amended their partnership agreement for paroxysmal nocturnal hemoglobinuria (PNH) treatment Empaveli, or Aspaveli as it is known in Europe.

Despite the popularity of generic and biosimilar drugs in Europe—the latter of which have struggled to catch on in the ...

As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...

EuroAPI, which is in the midst of a four-year restructuring plan, has sold its Haverhill manufacturing facility in the United Kingdom to Particle Dynamics as part of a share purchase agreement.

The Peetes have turned Gemtesa promotion into a family business, with former professional quarterback Rodney Peete now ...

Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...